Chronic kidney disease defined by 24-hour urinary albumin and silent brain infarction in community-dwelling older adults

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Albuminuria is a well-established marker of chronic kidney disease (CKD) and a known risk factor for stroke. However, its relationship with silent brain infarction (SBI), a key imaging marker of cerebral small vessel disease (CSVD), remains unclear. Importantly, no prior study has examined this association using quantitative 24-h urine collection. We conducted a cross-sectional study of 296 community-dwelling older adults (mean age: 68.7 years) who underwent brain magnetic resonance imaging (MRI) and comprehensive health screening, including 24-h urine sampling. SBI was identified in 26 participants (8.8%), and albuminuria (≥ 30 mg/day) in 30 (10.1%). In multivariable logistic regression (Model 1), age and hypertension were significantly associated with SBI, while estimated glomerular filtration rate was not. In Model 2, which included urinary indices, log-transformed 24-h urinary albumin was independently associated with SBI (odds ratio [OR]: 3.30; 95% confidence intervals [CI]: 1.38–7.87), and the association with hypertension lost significance. Sensitivity analyses excluding three macroalbuminuria cases produced similar results. Moderately increased albuminuria (30–299 mg/day), measured via 24-h urine collection, may serve as an early indicator of SBI due to CSVD, even in individuals with preserved renal function.

Article activity feed